STOCK TITAN

OHA is the Lead Left Arranger of Greenway Health’s Private Unitranche Financing

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
Oak Hill Advisors (OHA) served as the Lead Left Arranger of a private unitranche financing for Greenway Health, committing to half of the $375 million term loan used to refinance the company’s maturing syndicated first lien debt. OHA's industry-specialist investment team model positioned it to quickly and confidently diligence the opportunity, with its speed being a meaningful factor in closing the transaction. OHA has deployed over $30 billion in both liquid and private financings for over 130 portfolio companies since 2004 and maintains a distinctive understanding of healthcare information technology. Alan Schrager, Portfolio Manager and Senior Partner at OHA, stated that they believe Greenway Health is well-positioned for scalable and profitable growth. The transaction exemplifies the benefits of direct lending, offering flexibility, speed, and certainty, and is indicative of the current evolution in financing markets with ongoing constraints in syndicated markets driving increased demand for private financings by larger, historical issuers in syndicated markets.
Positive
  • None.
Negative
  • None.

Insights

The private unitranche financing arranged by Oak Hill Advisors for Greenway Health represents a significant transaction within the healthcare information technology sector. Unitranche financing combines senior and subordinated debt into a single loan with a blended interest rate, offering borrowers simplicity and potentially lower overall costs of capital. The commitment of OHA to half of the $375 million term loan is noteworthy, as it indicates confidence in Greenway Health's future performance and potential for scalable growth. This refinancing activity may signal a broader trend in the market where private financing solutions are increasingly sought after due to constraints in the syndicated loan market.

For stakeholders, this refinancing could imply a positive outlook on Greenway Health's financial stability and growth prospects. By refinancing maturing debt, the company may achieve more favorable terms and enhance its financial flexibility. The transaction also underscores the role of direct lending in providing liquidity to companies, particularly in an environment where traditional syndicated financing may be less accessible. This trend could have implications for other companies seeking refinancing in the near term, potentially leading to a rise in private credit opportunities.

OHA's involvement in the healthcare information technology sector is of particular interest, given their historical investments and understanding of the market. The focus on this niche indicates a strategic approach to investment, leveraging specialized industry knowledge. For the broader market, this could reflect a shift toward specialized lending where investors with deep sector expertise play a pivotal role. The increasing demand for private financings by larger issuers traditionally active in syndicated markets might also suggest a structural change in the way companies approach their financing needs.

From a market perspective, this deal may highlight the attractiveness of healthcare IT as an investment area, especially in the context of the ongoing digital transformation in healthcare. Greenway Health's positioning in the ambulatory market and the anticipated profitable growth could draw attention to the sector's potential for innovation and expansion. Investors and companies alike may look to this transaction as a barometer for the health of the private credit market and the healthcare IT industry's capacity for attracting significant capital investments.

The legal implications of a private unitranche financing deal are multifaceted, particularly regarding the structuring and negotiation of terms. The transaction between OHA and Greenway Health would have involved a thorough due diligence process, ensuring compliance with regulatory requirements and assessing potential risks. The commitment by OHA to a substantial portion of the term loan suggests a strong contractual framework that likely includes covenants and conditions tailored to the specific needs and risks of the healthcare IT industry. The legal intricacies of such a deal may set precedents for future transactions, especially in terms of the documentation and legal safeguards required for private financings in specialized markets.

Additionally, the transaction's speed, as highlighted by OHA, may indicate a streamlined legal process that could become a benchmark for efficiency in closing similar deals. This efficiency is particularly relevant in an evolving financing market where the ability to execute transactions quickly can be a competitive advantage. As the demand for private credit solutions grows, the legal strategies and structures implemented in this deal could influence the negotiation and execution of future financings within the industry.

New York, New York, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Oak Hill Advisors (“OHA”) served as the Lead Left Arranger of a private unitranche financing for Greenway Health, a provider of electronic health record and practice management solutions to the U.S. ambulatory market. OHA committed to half of the $375 million term loan used to refinance the company’s maturing syndicated first lien debt.

OHA’s industry-specialist investment team model positioned it to quickly and confidently diligence the opportunity, with its speed being a meaningful factor in closing the transaction. OHA is one of the earliest investors in software credit, having deployed over $30 billion in both liquid and private financings for over 130 portfolio companies since 2004, and maintains a distinctive understanding of healthcare information technology through its historical investments and ongoing coverage of businesses similar to Greenway Health.

“This refinancing exemplifies the many benefits of direct lending: the flexibility, the speed, the certainty,” said Alan Schrager, Portfolio Manager and Senior Partner at OHA. “We believe that Greenway Health is well-positioned for scalable and profitable growth, and we look forward to helping advance the company’s execution.”

This transaction is one of several recent private solutions in which OHA committed in size to refinance upcoming maturities in syndicated markets. We believe that it is exemplary of the current evolution in financing markets with ongoing constraints in syndicated markets driving increased demand for private financings by larger, historical issuers in syndicated markets. OHA expects this financing opportunity to continue to grow in 2024 for high-quality borrowers to address near-term maturities.

###

About OHA: Oak Hill Advisors (OHA) is a leading global credit-focused alternative asset manager with over 30 years of investment experience. OHA works with institutions and individuals and seeks to deliver a consistent track record of risk-adjusted returns with downside focus. The firm manages approximately $63 billion of capital across credit strategies in commingled funds, collateralized loan obligations and single investor mandates as of September 30, 2023. OHA’s emphasis on long-term partnerships with companies, sponsors and other partners provides access to a proprietary opportunity set allowing for customized credit solutions with strength across all market cycles.

With over 420 experienced professionals across six global offices, OHA brings a collaborative approach to offering investors a single platform to meet their diverse credit needs. OHA is the private markets platform of T. Rowe Price Group, Inc. (NASDAQ – GS: TROW). For more information, please visit oakhilladvisors.com.

About Greenway Health: Greenway Health provides electronic health records (EHR), practice management, and revenue cycle management solutions that help practices in multiple specialties grow profitably, remain compliant, work more efficiently, and improve patient outcomes. Its team of clinical, financial, and technology experts serves as trusted advisors, committed to enabling successful providers, empowering patients, and building healthier communities. Greenway works with thousands of providers across multiple specialties, translating into millions of lives touched daily by its solutions. For more information on Greenway and its holistic solutions, visit www.greenwayhealth.com, call 877-537-0063, or follow Greenway on LinkedIn, X, Facebook, and Instagram. 

Attachment


FAQ

What is the amount of the term loan committed by OHA for Greenway Health's refinancing?

OHA committed to half of the $375 million term loan used to refinance the company’s maturing syndicated first lien debt.

How much has OHA deployed in both liquid and private financings since 2004?

OHA has deployed over $30 billion in both liquid and private financings for over 130 portfolio companies since 2004.

Who stated that they believe Greenway Health is well-positioned for scalable and profitable growth?

Alan Schrager, Portfolio Manager and Senior Partner at OHA, stated that they believe Greenway Health is well-positioned for scalable and profitable growth.

What are the benefits of direct lending exemplified in the transaction?

The transaction exemplifies the benefits of direct lending, offering flexibility, speed, and certainty.

What is indicative of the current evolution in financing markets according to OHA?

The transaction is indicative of the current evolution in financing markets with ongoing constraints in syndicated markets driving increased demand for private financings by larger, historical issuers in syndicated markets.

T Rowe Price Group Inc

NASDAQ:TROW

TROW Rankings

TROW Latest News

TROW Stock Data

25.41B
217.11M
2.04%
77.19%
4.52%
Asset Management
Security & Commodity Brokers, Dealers, Exchanges & Services
Link
United States of America
BALTIMORE